Excipients buffers

However, it may also be possible that the buffer negatively influences the solubility of the drug and other excipients. Buffer salts can either increase or decrease the solubility of organic compounds in water. The effect depends on a combination of the polarity of the solute and of the salt. Nonpolar solutes are solubilized (salted in) by less polar organic salts and are desolubilized (salted out) by polar salts. Conversely, polar solutes are salted in by polar salts and salted out by organic salts. It was shown that for a semipolar solute such as ampicillin, strong electrolytes... 

Another degree of freedom relates to the choice of a suitable excipient/ buffer system, quite distinct from ensuring the correct pH value. The complex phase relationships of water PHC-salt systems have already been mentioned (see also Shalaev et It is imperative to be aware... 

Figure 13.10 Effect of the surfactant nature on the electropherograms of a complex antitussive preparation containing 14 solutes (analgesic, antitussive, antipyretic principles, conservatives and excipients). Buffer 0.02 M phosphate-borate, pH 9. Capillary 50 pm, 65 cm fused silica. Detection UV 210 nm. Adapted from [47].

Single-dose preparations intended for use in eye surgery do not contain excipient ingredients, in order to avoid tissue irritation. However, multiple-dose containers may require antioxidants (qv), antimicrobial preservatives, or buffers to maintain stabiHty and stefiHty. Such solutions are packaged in polyethylene flexible dropper units called droptainers or in glass dropper botdes. 

A plausible mechanism for the erosion of devices that contain Mg(OH)2 is shown in Fig. 14 (2). According to this mechanism, the base stabilizes the interior of the device and erosion can only occur in the surface layers where the base has been eluted or neutralized. This is believed to occur by water intrusion into the matrix and diffusion of the slightly water-soluble basic excipient out of the device where it is neutralized by the external buffer. Polymer erosion then occurs in the base-depleted layer. 

Because acid excipients can be used to achieve rapid polymer erosion, the possibility of preparing devices useful for oral delivery was investigated (31). In one such system, 2 wt% phthalic anhydride was incorporated into a polymer prepared from the diketene acetal, trans-cyclohexanedimethanol and C-labeled 1,6-hexanediol and polymer erosion followed in a pH 7 buffer and in pH 1.5 canine... 

Vishwavidyalaya et al. [22] used a difference-spectrophotometric method for the estimation of primaquine phosphate in tablets. One portion of powdered tablets, equivalent to 7.5 mg of primaquine phosphate, was extracted with hydrochloric acid-potassium chloride buffer (pH 2) and a second portion was extracted with phosphate buffer (pH 10). Primaquine phosphate was determined from the difference in absorbance of the acid and alkaline extracts at 254.2 nm. The calibration graph was rectilinear from 2 to 14 pg/mL of primaquine phosphate. Recovery was 98.6% and no interference was observed from excipients. Results compared with those by the British Pharmacopoeial method. 

Neumega is the tradename given to the IL-ll-based product approved for the prevention of thrombocytopenia. The product is produced in engineered E. coli cells and is presented as a purified product in freeze-dried format. Excipients include phosphate buffer salts and glycine. It is reconstituted (with water for injections) to a concentration of 5 mg ml-1 before s.c. administration. 

After initial cell fermentation and product extraction from the producer cells, the crude preparation is subject to multiple chromatographic steps, including ion-exchange, hydrophobic interaction chromatography and gel-filtration chromatography. The purified product is presented in lyophilized form in vials (1 mg active/vial) and excipients include a phosphate buffer, sodium chloride and serum albumin. 

Neorecormon (tradename, also known as epoetin beta) is a recombinant human EPO first approved for medical use in the EU in 1997. It is indicated for the treatment of anaemia associated with various medical conditions, most commonly chronic renal failure and cancer patients receiving chemotherapy. Neorecormon is produced by recombinant DNA technology in a CHO cell line and is manufactured as outlined in Figure 10.5. It is presented in lyophilized format at various strengths (500-10 000 IU/vial) and contains phosphate buffer, sodium chloride, calcium chloride, urea, polysorbate and various amino acids as excipients. 

The rHBsAg is produced in an engineered S. cerevisiae strain and is likely purified subsequent to fermentation by a procedure somewhat similar to that presented in Figure 13.10. The final product is presented as a sterile suspension of the antigen absorbed onto aluminium hydroxide (adjuvant), in either single-use vials or pre-filled syringes. It also contains NaCl and phosphate buffer components as excipients. It is intended for i.m. injection, usually as 10 pg in a volume of 0.5 ml for infants/children or 20 pg (in 1.0 ml) for adults. The normal dosage schedule entails initial administration followed by boosters after 1 and 6 months. 

Dobutaraine hydrochloride may be determined spectrophotometrically in 0.5 M hydrochloric acid at the maximum of 278 nm. If excipients interfere, the drug may be extracted into ethyl acetate from pH 9 buffer followed by extraction into 0.5 M hydrochloric acid for the UV measurement. 

The use of flow cells may generate variability in absorbance readings. Air bubbles can become caught in the cell, either introduced via a water source containing bubbles or by air entering inadvertently into poorly secured sample lines. Flow rate and dwell time should be evaluated so that the absorbance reading can be determined to have reached a steady plateau. Cells need to be cleaned frequently to avoid build up of drug, excipient, surfactant, or buffer salts from the dissolution medium. 

The Committee for Proprietary Medicinal Products [8] applied the BCS, with certain requirements, to dispense with bioequivalency tests if the active pharmaceutical ingredient is class I and the in vitro dissolution of the finished dosage form is fast [9], An active substance is considered highly soluble if the amount contained in the HDS of an IR product is dissolved in 250 ml of each of three buffers within the range of pH 1-8 at 37°C (e.g., pH 1.0, 4.6, and 6.8). There should be linear and complete absorption, which indicates HP to reduce the possibility of an IR dosage form influencing the bioavailability [8], The similarity of the dissolution profiles of the test and reference products is demonstrated in each of three buffers within the range of pH 1-8 at 37°C (e.g., pH 1.0,4.6, and 6.8). If there is rapid dissolution of the product, where at least 85% of the active substance is dissolved within 15 min, no further comparison of the test and reference is required. Further requirements include that excipients be well established and have no interaction with the pharmacokinetics of the active substance and that the method of manufacture of finished product... 

Unlike the previous techniques, sensitivity is not an issue for AAA. There are few interfering substances because the method involves hydrolysis, derivatization, and chromatography with detection at a unique wavelength. Most excipients will not affect the hydrolysis step, but one has to be careful to ensure that the amino acids used to quantitate the protein are not destroyed. In addition, it must be determined if the excipients interfere with the derivatization chemistry or the chromatography. A BSA standard in the same buffer formulation is routinely run in parallel to the target protein to ensure the accuracy of the method. 

Once the protein is purified, it will be formulated to produce the drug product. This could be as simple as diluting the protein in phosphate-buffered saline, or as complex as addition of excipients and lyophilization. The mark of... 

In some cases, sample preparation for CZE requires only the dilution of the sample, mostly to accommodate detection (for signal and linearity of response). However, as was previously mentioned, sample characteristics such as viscosity, buffer composition (pH and excipients), and salt content can especially affect electrophoretic injection and performance. 

Because of antibody-based selectivity, ELISAs are capable of handling samples that are impure or only semipurihed. It is possible to perform ELISAs in a variety of matrices. This is in contrast to other methods such as HPLC that require relatively pure material. During the development and validation of the ELISA method, it needs to be demonstrated that the ELISA is not affected by interfering substances that could be in the test sample, such as buffers, salts, contaminating proteins, and excipients. It also needs to be demonstrated that the conjugated antibody does not bind nonspecihcally to the coated solid phase. 

There are two primary questions that a formulator will often ask regarding a biopharmaceutical. First and foremost, what excipients (inactive ingredients like chemical stabilizers, buffers, and toxicifiers) and solution conditions (i.e., pH, temperature) offer the greatest stabilization Second, how long will the chosen... 

Although the potential to use Caco-2 cells to screen large numbers of formulations under carefully controlled experimental conditions appears attractive, the assumption that this model is suitable to evaluate drug formulations should not be made. In fact, the utility of Caco-2 cells in formulation evaluation is limited because these cells are sensitive to pharmaceutical excipients.112 In addition, the dilution of formulations into the simple buffer solutions used in permeability studies is likely to break the physical integrity of the... 

Figure 8 shows a typical F4PLC chromatogram of the tablet extract illustrating the complexity of the sample, which contains numerous natural components, excipients and additives. During the SP method development, it was found that extraction with a neutral aqueous buffer was problematic due the loss of one of the active ingredients by hydrolysis. The use of the PTFE filter was also important because this hydrolysis product, which is highly hydrophobic, was absorbed by nylon filters under the filtration conditions. 

---